EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Omic Characterization of Epithelial–Mesenchymal Transition: Lipidomic and Metabolomic Profiles as Key Markers of TGF-β-Induced Transition in Huh7 Hepatocellular Carcinoma

Agnese Bertoldi iD, Gaia Cusumano iD, Eleonora Calzoni iD, Husam B R Alabed iD, Roberto Maria Pellegrino iD, Sandra Buratta, Lorena Urbanelli iD, Carla Emiliani

Cells · 2025

DOI: 10.3390/cells14161233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Agnese Bertoldi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Biology and Biotechnology, University of Perugia, Via del Giochetto, 06123 Perugia, Italy. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Carcinoma, Hepatocellular, Liver Neoplasms, Lipidomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the European Union-NextGenerationEU under the Italian Ministry of University and Research (MUR) National Innovation Ecosystem grant ECS00000041-VITALITY-CUP J9…, the European Union—NextGenerationEU under the Italian Ministry of University and Research (MUR) National Innovation Ecosystem grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial–mesenchymal transition (EMT) is a key process in cancer progression and fibrogenesis. In this study, EMT was induced in Huh7 hepatocellular carcinoma cells via TGF-β1 treatment, and the resulting lipidomic and metabolomic alterations were characterized. Morphological changes and protein marker analyses confirmed the transition to a mesenchymal phenotype, with reduced E-cadherin and increased vimentin and N-cadherin expression. Lipidomic profiling revealed a dose-dependent reorganization of membrane lipids, with a pronounced increase in the levels of ceramides, cholesteryl esters, and lysophospholipids, consistent with alterations in membrane structure, potential cellular stress, and modulation of inflammatory pathways. Changes in the content of phospholipid classes, including phosphatidylethanolamines and phosphatidylserines, indicate possible variations in membrane dynamics and potentially point to modifications in mitochondrial function, cellular stress responses, and redox balance. Metabolomic analysis further indicates an alteration of choline and phosphatidylcholine metabolism, consistent with a shift from de novo membrane synthesis toward lipid turnover. Reduced glycolytic capacity and modified acylcarnitine levels indicated impaired metabolic flexibility and mitochondrial efficiency. The integration of phenotypic, lipidomic, and metabolomic data suggests that TGF-β1 induces EMT and drives a coordinated metabolic reprogramming. These findings highlight the involvement of lipid and energy metabolism in sustaining EMT and suggest that specific metabolic reprogramming events characterize the mesenchymal shift in hepatocellular carcinoma. By exploring this process in a tumor-specific context, we aim to deepen our understanding of EMT complexity and its implications for tumor progression and therapeutic vulnerability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionCarcinoma, HepatocellularLiver NeoplasmsLipidomicsMetabolomicsTransforming Growth Factor beta1Transforming Growth Factor betaMetabolomeHumansCell Line, TumorLipid MetabolismMultiomics

Stichwörter der Autor:innen

TGF-β1 signalingepithelial–mesenchymal transition (EMT)hepatocellular carcinoma (HCC)lipidomicmembrane remodelingmetabolomic

Substanzen

Transforming Growth Factor beta1Transforming Growth Factor beta

Autor:innen und Institutionen

  • Department of Chemistry, Biology and Biotechnology, University of Perugia, Via del Giochetto, 06123 Perugia, Italy.
  • Centro di Digitalizzazione del Patrimonio Culturale (CeDiPa), University of Perugia, 06123 Perugia, Italy.
  • Centro di Eccellenza Materiali Innovativi Nanostrutturati (CEMIN), University of Perugia, Via del Giochetto, 06123 Perugia, Italy.

ORCID-Profile: Agnese Bertoldi, Gaia Cusumano, Eleonora Calzoni, Husam B R Alabed, Roberto Maria Pellegrino, Lorena Urbanelli

Förderung

  • the European Union-NextGenerationEU under the Italian Ministry of University and Research (MUR) National Innovation Ecosystem grant ECS00000041-VITALITY-CUP J9…
  • the European Union—NextGenerationEU under the Italian Ministry of University and Research (MUR) National Innovation Ecosystem grant

Zitieren

APA

Bertoldi, A., Cusumano, G., Calzoni, E., Alabed, H. B. R., Pellegrino, R. M., Buratta, S., Urbanelli, L., & Emiliani, C. (2025). Multi-Omic Characterization of Epithelial–Mesenchymal Transition: Lipidomic and Metabolomic Profiles as Key Markers of TGF-β-Induced Transition in Huh7 Hepatocellular Carcinoma. Cells. https://doi.org/10.3390/cells14161233

Vancouver

Bertoldi A, Cusumano G, Calzoni E, Alabed HBR, Pellegrino RM, Buratta S, et al. Multi-Omic Characterization of Epithelial–Mesenchymal Transition: Lipidomic and Metabolomic Profiles as Key Markers of TGF-β-Induced Transition in Huh7 Hepatocellular Carcinoma. Cells. 2025. doi:10.3390/cells14161233

BibTeX
@article{Bertoldi2025,
  author = {Bertoldi, Agnese and Cusumano, Gaia and Calzoni, Eleonora and Alabed, Husam B R and Pellegrino, Roberto Maria and Buratta, Sandra and Urbanelli, Lorena and Emiliani, Carla},
  title = {Multi-Omic Characterization of Epithelial–Mesenchymal Transition: Lipidomic and Metabolomic Profiles as Key Markers of TGF-β-Induced Transition in Huh7 Hepatocellular Carcinoma},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14161233}
}
Kostenlos starten →